{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:36:58Z","timestamp":1777905418945,"version":"3.51.4"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["UM1HG012053"],"award-info":[{"award-number":["UM1HG012053"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["RM1HG011123"],"award-info":[{"award-number":["RM1HG011123"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["R21HG010747"],"award-info":[{"award-number":["R21HG010747"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Pro00106476"],"award-info":[{"award-number":["Pro00106476"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Pro00090878"],"award-info":[{"award-number":["Pro00090878"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gimopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine Open"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.gimo.2025.103474","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:02:01Z","timestamp":1763629321000},"page":"103474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cell modeling and rescue of a novel noncoding genetic cause of glycogen storage disease IX"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8465-333X","authenticated-orcid":false,"given":"Apoorva K.","family":"Iyengar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0512-1341","authenticated-orcid":false,"given":"Xue","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhodricia A.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexias","family":"Safi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0853-1231","authenticated-orcid":false,"given":"Karynne","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca L.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8261-7640","authenticated-orcid":false,"given":"Shannon","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4066-2060","authenticated-orcid":false,"given":"M. Makenzie","family":"Beaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruthi","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1616-2448","authenticated-orcid":false,"given":"Jessica X.","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9647-0861","authenticated-orcid":false,"given":"Michael J.","family":"Bamshad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7284-9335","authenticated-orcid":false,"given":"William H.","family":"Majoros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4924-9010","authenticated-orcid":false,"given":"R. Catherine","family":"Rehder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deeksha S.","family":"Bali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7232-2143","authenticated-orcid":false,"given":"Andrew S.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6106-2772","authenticated-orcid":false,"given":"Gregory E.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8251-909X","authenticated-orcid":false,"given":"Priya S.","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7629-061X","authenticated-orcid":false,"given":"Timothy E.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.gimo.2025.103474_bib1","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1056\/NEJMoa1714458","article-title":"Effect of genetic diagnosis on patients with previously undiagnosed disease","volume":"379","author":"Splinter","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gimo.2025.103474_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.rare.2024.100022","article-title":"The diagnostic odyssey for children living with a rare disease - caregiver and patient perspectives: a narrative review with recommendations","volume":"2","author":"Pavisich","year":"2024","journal-title":"Rare"},{"issue":"9","key":"10.1016\/j.gimo.2025.103474_bib3","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s41431-024-01604-z","article-title":"Time to diagnosis and determinants of diagnostic delays of people living with a rare disease: results of a Rare Barometer retrospective patient survey","volume":"32","author":"Faye","year":"2024","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"10.1016\/j.gimo.2025.103474_bib4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nchembio.1199","article-title":"Target identification and mechanism of action in chemical biology and drug discovery","volume":"9","author":"Schenone","year":"2013","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.gimo.2025.103474_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2023.102568","article-title":"Future prospects for human genetics and genomics in drug discovery","volume":"80","author":"Ghoussaini","year":"2023","journal-title":"Curr Opin Struct Biol"},{"issue":"12","key":"10.1016\/j.gimo.2025.103474_bib6","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.gimo.2025.103474_bib7","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gimo.2025.103474_bib8","doi-asserted-by":"crossref","DOI":"10.1542\/peds.105.1.e10","article-title":"Incidence of inborn errors of metabolism in British Columbia, 1969-1996","volume":"105","author":"Applegarth","year":"2000","journal-title":"Pediatrics"},{"issue":"25","key":"10.1016\/j.gimo.2025.103474_bib9","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.3748\/wjg.v29.i25.3932","article-title":"Glycogen storage diseases: an update","volume":"29","author":"G\u00fcm\u00fc\u015f","year":"2023","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.gimo.2025.103474_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/01913123.2011.601404","article-title":"Glycogen storage diseases: a brief review and update on clinical features, genetic abnormalities, pathologic features, and treatment","volume":"35","author":"Hicks","year":"2011","journal-title":"Ultrastruct Pathol"},{"issue":"4","key":"10.1016\/j.gimo.2025.103474_bib11","first-page":"415","article-title":"Hepatic glycogen storage disorders: what have we learned in recent years?","volume":"18","author":"Burda","year":"2015","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.gimo.2025.103474_bib12","first-page":"23","article-title":"Regression of hepatocellular adenomas with strict dietary therapy in patients with glycogen storage disease type I","volume":"18","author":"Beegle","year":"2015","journal-title":"JIMD Rep"},{"issue":"1","key":"10.1016\/j.gimo.2025.103474_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000351022","article-title":"Impaired bone metabolism in glycogen storage disease type 1 is associated with poor metabolic control in type 1a and with granulocyte colony-stimulating factor therapy in type 1b","volume":"81","author":"Melis","year":"2014","journal-title":"Horm Res Paediatr"},{"issue":"1","key":"10.1016\/j.gimo.2025.103474_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13073-022-01026-w","article-title":"A guide for the diagnosis of rare and undiagnosed disease: beyond the exome","volume":"14","author":"Marwaha","year":"2022","journal-title":"Genome Med"},{"issue":"12","key":"10.1016\/j.gimo.2025.103474_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2024.101249","article-title":"Noncoding variants are a rare cause of recessive developmental disorders in trans with coding variants","volume":"26","author":"Lord","year":"2024","journal-title":"Genet Med"},{"key":"10.1016\/j.gimo.2025.103474_bib16","article-title":"The Human Gene Mutation Database (HGMD) and its exploitation in the study of mutational mechanisms","author":"Cooper","year":"2006","journal-title":"Curr Protoc Bioinformatics"},{"issue":"27","key":"10.1016\/j.gimo.2025.103474_bib17","doi-asserted-by":"crossref","first-page":"11093","DOI":"10.1073\/pnas.1101135108","article-title":"Using positional distribution to identify splicing elements and predict pre-mRNA processing defects in human genes","volume":"108","author":"Lim","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.gimo.2025.103474_bib18","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/embor.2009.170","article-title":"Missed threads. The impact of pre-mRNA splicing defects on clinical practice","volume":"10","author":"Baralle","year":"2009","journal-title":"EMBO Rep"},{"issue":"5","key":"10.1016\/j.gimo.2025.103474_bib19","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41431-018-0099-1","article-title":"Exome sequencing has higher diagnostic yield compared to simulated disease-specific panels in children with suspected monogenic disorders","volume":"26","author":"Dillon","year":"2018","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"10.1016\/j.gimo.2025.103474_bib20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/cge.12654","article-title":"Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care","volume":"89","author":"Sawyer","year":"2016","journal-title":"Clin Genet"},{"issue":"7542","key":"10.1016\/j.gimo.2025.103474_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nature14135","article-title":"Large-scale discovery of novel genetic causes of developmental disorders","volume":"519","year":"2015","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.gimo.2025.103474_bib22","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/humu.22450","article-title":"A post-hoc comparison of the utility of sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases","volume":"34","author":"Neveling","year":"2013","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.gimo.2025.103474_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1101\/gr.238444.118","article-title":"Pathogenicity and selective constraint on variation near splice sites","volume":"29","author":"Lord","year":"2019","journal-title":"Genome Res"},{"issue":"1","key":"10.1016\/j.gimo.2025.103474_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13073-022-01087-x","article-title":"A systematic analysis of splicing variants identifies new diagnoses in the 100,000 Genomes Project","volume":"14","author":"Blakes","year":"2022","journal-title":"Genome Med"},{"issue":"1","key":"10.1016\/j.gimo.2025.103474_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13073-022-01073-3","article-title":"Recommendations for clinical interpretation of variants found in non-coding regions of the genome","volume":"14","author":"Ellingford","year":"2022","journal-title":"Genome Med"},{"key":"10.1016\/j.gimo.2025.103474_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giad085","article-title":"Computational prediction of human deep intronic variation","volume":"12","author":"Barbosa","year":"2022","journal-title":"Gigascience"},{"issue":"2","key":"10.1016\/j.gimo.2025.103474_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/humu.24306","article-title":"Pseudoexon activation in disease by non-splice site deep intronic sequence variation - wild type pseudoexons constitute high-risk sites in the human genome","volume":"43","author":"Petersen","year":"2022","journal-title":"Hum Mutat"},{"issue":"5","key":"10.1016\/j.gimo.2025.103474_bib28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.gimo.2025.103474_bib29","article-title":"Analysis of pathogenic pseudoexons reveals novel mechanisms driving cryptic splicing","volume":"12","author":"Keegan","year":"2021","journal-title":"Front Genet"},{"issue":"4","key":"10.1016\/j.gimo.2025.103474_bib30","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1742-4658.2009.07520.x","article-title":"Alternative splicing: role of pseudoexons in human disease and potential therapeutic strategies","volume":"277","author":"Dhir","year":"2010","journal-title":"FEBS J"},{"issue":"14","key":"10.1016\/j.gimo.2025.103474_bib31","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1093\/nar\/gkw533","article-title":"Splice-switching antisense oligonucleotides as therapeutic drugs","volume":"44","author":"Havens","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"10.1016\/j.gimo.2025.103474_bib32","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","article-title":"Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy","volume":"86","author":"Chiriboga","year":"2016","journal-title":"Neurology"},{"issue":"17","key":"10.1016\/j.gimo.2025.103474_bib33","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1056\/NEJMoa1813279","article-title":"Patient-customized oligonucleotide therapy for a rare genetic disease","volume":"381","author":"Kim","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.gimo.2025.103474_bib34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s40259-024-00644-7","article-title":"Splice-modulating antisense oligonucleotides as therapeutics for inherited metabolic diseases","volume":"38","author":"Chen","year":"2024","journal-title":"BioDrugs"},{"issue":"23","key":"10.1016\/j.gimo.2025.103474_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163464","article-title":"A splice-switching oligonucleotide treatment ameliorates glycogen storage disease type 1a in mice with G6PC c.648G>T","volume":"133","author":"Ito","year":"2023","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.gimo.2025.103474_bib36","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.ymthe.2020.06.015","article-title":"Delivery of oligonucleotides to the liver with GalNAc: from research to registered therapeutic drug","volume":"28","author":"Debacker","year":"2020","journal-title":"Mol Ther"},{"issue":"14","key":"10.1016\/j.gimo.2025.103474_bib37","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.gimo.2025.103474_bib38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"7414","key":"10.1016\/j.gimo.2025.103474_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","year":"2012","journal-title":"Nature"},{"issue":"D1","key":"10.1016\/j.gimo.2025.103474_bib40","doi-asserted-by":"crossref","first-page":"D882","DOI":"10.1093\/nar\/gkz1062","article-title":"New developments on the Encyclopedia of DNA Elements (ENCODE) data portal","volume":"48","author":"Luo","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.gimo.2025.103474_bib41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ymgme.2013.12.008","article-title":"Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene","volume":"111","author":"Bali","year":"2014","journal-title":"Mol Genet Metab"},{"issue":"5","key":"10.1016\/j.gimo.2025.103474_bib42","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/jmg.37.5.376","article-title":"Phosphorylase kinase deficient liver glycogenosis: progression to cirrhosis in infancy associated with PHKG2 mutations (H144Y and L225R)","volume":"37","author":"Burwinkel","year":"2000","journal-title":"J Med Genet"},{"issue":"3","key":"10.1016\/j.gimo.2025.103474_bib43","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ymgme.2020.10.004","article-title":"Benign or not benign? Deep phenotyping of liver glycogen Storage Disease IX","volume":"131","author":"Fernandes","year":"2020","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.1016\/j.gimo.2025.103474_bib44","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41439-021-00172-8","article-title":"A female patient with GSD IXc developing multiple and recurrent hepatocellular carcinoma: a case report and literature review","volume":"8","author":"Kido","year":"2021","journal-title":"Hum Genome Var"},{"issue":"1","key":"10.1016\/j.gimo.2025.103474_bib45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13023-022-02284-y","article-title":"Liver transplantation in glycogen storage disease: a single-center experience","volume":"17","author":"Beyzaei","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.gimo.2025.103474_bib46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/humu.23348","article-title":"VariantValidator: accurate validation, mapping, and formatting of sequence variation descriptions","volume":"39","author":"Freeman","year":"2018","journal-title":"Hum Mutat"},{"issue":"Database issue","key":"10.1016\/j.gimo.2025.103474_bib47","doi-asserted-by":"crossref","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: public archive of relationships among sequence variation and human phenotype","volume":"42","author":"Landrum","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"10.1016\/j.gimo.2025.103474_bib48","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/s41436-019-0561-7","article-title":"Liver fibrosis during clinical ascertainment of glycogen storage disease type III: a need for improved and systematic monitoring","volume":"21","author":"Halaby","year":"2019","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.gimo.2025.103474_bib49","first-page":"41","article-title":"Natural progression of canine glycogen storage disease Type IIIa","volume":"66","author":"Brooks","year":"2016","journal-title":"Comp Med"},{"issue":"6","key":"10.1016\/j.gimo.2025.103474_bib50","first-page":"1784","article-title":"Progress and prospects of elastography techniques in the evaluation of fibrosis in chronic liver disease","volume":"20","author":"Wang","year":"2024","journal-title":"Arch Med Sci"},{"issue":"4","key":"10.1016\/j.gimo.2025.103474_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108597","article-title":"Progressive liver disease and dysregulated glycogen metabolism in murine GSD IX \u03b32 models human disease","volume":"143","author":"Gibson","year":"2024","journal-title":"Mol Genet Metab"},{"issue":"3","key":"10.1016\/j.gimo.2025.103474_bib52","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","article-title":"Predicting splicing from primary sequence with deep learning","volume":"176","author":"Jaganathan","year":"2019","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.gimo.2025.103474_bib53","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0968-0004(98)01208-0","article-title":"A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance","volume":"23","author":"Nagy","year":"1998","journal-title":"Trends Biochem Sci"},{"issue":"6509","key":"10.1016\/j.gimo.2025.103474_bib54","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.aaz1776","article-title":"The GTEx Consortium atlas of genetic regulatory effects across human tissues","volume":"369","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.gimo.2025.103474_bib55","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2337\/diacare.24.2.382","article-title":"Renal gluconeogenesis: its importance in human glucose homeostasis","volume":"24","author":"Gerich","year":"2001","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.gimo.2025.103474_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/gim.2014.128","article-title":"Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics","volume":"16","author":"Kishnani","year":"2014","journal-title":"Genet Med"},{"issue":"7809","key":"10.1016\/j.gimo.2025.103474_bib57","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.gimo.2025.103474_bib58","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/nat.2013.0454","article-title":"A chemical view of oligonucleotides for exon skipping and related drug applications","volume":"24","author":"J\u00e4rver","year":"2014","journal-title":"Nucleic Acid Ther"},{"issue":"3","key":"10.1016\/j.gimo.2025.103474_bib59","article-title":"Antisense oligonucleotide (AON)-based therapy for Leber congenital amaurosis caused by a frequent mutation in CEP290","volume":"1","author":"Collin","year":"2012","journal-title":"Mol Ther Nucleic Acids"},{"issue":"4","key":"10.1016\/j.gimo.2025.103474_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122966","article-title":"Functional characterization of the spf\/ash splicing variation in OTC deficiency of mice and man","volume":"10","author":"Rivera-Barahona","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.gimo.2025.103474_bib61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-1-4939-8651-4_5","article-title":"Tips to design effective splice-switching antisense oligonucleotides for exon skipping and exon inclusion","volume":"1828","author":"Maruyama","year":"2018","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10.1016\/j.gimo.2025.103474_bib62","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/nar\/gkad067","article-title":"Chemistry, structure and function of approved oligonucleotide therapeutics","volume":"51","author":"Egli","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.gimo.2025.103474_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13073-019-0690-2","article-title":"Recommendations for application of the functional evidence PS3\/BS3 criterion using the ACMG\/AMP sequence variant interpretation framework","volume":"12","author":"Brnich","year":"2019","journal-title":"Genome Med"},{"issue":"2","key":"10.1016\/j.gimo.2025.103474_bib64","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.3390\/ijms24021562","article-title":"Minigene splicing assays and long-read sequencing to unravel pathogenic deep-intronic variants in PAX6 in congenital aniridia","volume":"24","author":"Tamayo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.gimo.2025.103474_bib65","article-title":"Induced pluripotent stem cell (iPSC) modeling validates reduced GBE1 enzyme activity due to a novel variant, p.Ile694Asn, found in a patient with suspected glycogen storage disease IV","volume":"39","author":"Naito","year":"2024","journal-title":"Mol Genet Metab Rep"},{"issue":"9","key":"10.1016\/j.gimo.2025.103474_bib66","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.3390\/ijms22094536","article-title":"Lymphoblastoid cell lines as models to study mitochondrial function in neurological disorders","volume":"22","author":"Annesley","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.gimo.2025.103474_bib67","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.molcel.2018.01.017","article-title":"Combinatorial CRISPR-Cas9 metabolic screens reveal critical redox control points dependent on the KEAP1-NRF2 regulatory axis","volume":"69","author":"Zhao","year":"2018","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.gimo.2025.103474_bib68","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41598-023-51073-5","article-title":"Genetically engineered HEK cells as a valuable tool for studying electroporation in excitable cells","volume":"14","author":"Batista Napotnik","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.gimo.2025.103474_bib69","series-title":"GeneReviews\u00ae","article-title":"Phosphorylase kinase deficiency","author":"Herbert","year":"1993"},{"issue":"1","key":"10.1016\/j.gimo.2025.103474_bib70","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1038\/s41467-021-23663-2","article-title":"A deep learning approach to identify gene targets of a therapeutic for human splicing disorders","volume":"12","author":"Gao","year":"2021","journal-title":"Nat Commun"},{"issue":"7971","key":"10.1016\/j.gimo.2025.103474_bib71","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/s41586-023-06277-0","article-title":"A framework for individualized splice-switching oligonucleotide therapy","volume":"619","author":"Kim","year":"2023","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.gimo.2025.103474_bib72","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1177\/15353702221082612","article-title":"Mechanisms of disease-associated SINE-VNTR-Alus","volume":"247","author":"Pfaff","year":"2022","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.gimo.2025.103474_bib73","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/DDDT.S97635","article-title":"Eteplirsen in the treatment of Duchenne muscular dystrophy","volume":"11","author":"Lim","year":"2017","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"10.1016\/j.gimo.2025.103474_bib74","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.gimo.2025.103474_bib75","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.ymthe.2017.05.019","article-title":"Glycogen reduction in myotubes of late-onset Pompe disease patients using antisense technology","volume":"25","author":"Goina","year":"2017","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.gimo.2025.103474_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102133","article-title":"Tissue pharmacokinetics of antisense oligonucleotides","volume":"35","author":"B\u00e4ckstr\u00f6m","year":"2024","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.gimo.2025.103474_bib77","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.omtn.2017.07.003","article-title":"Strategies for in vivo screening and mitigation of hepatotoxicity associated with antisense drugs","volume":"8","author":"Kamola","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"10.1016\/j.gimo.2025.103474_bib78","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43856-023-00419-1","article-title":"N = 1 Collaborative. Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders","volume":"4","author":"Lauffer","year":"2024","journal-title":"Commun Med (Lond)"},{"issue":"11","key":"10.1016\/j.gimo.2025.103474_bib79","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.nmd.2019.09.007","article-title":"Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: interim efficacy and safety results from the Phase 2 NURTURE study","volume":"29","author":"De Vivo","year":"2019","journal-title":"Neuromuscul Disord"}],"container-title":["Genetics in Medicine Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949774425015134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949774425015134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:49:02Z","timestamp":1777639742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949774425015134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":79,"alternative-id":["S2949774425015134"],"URL":"https:\/\/doi.org\/10.1016\/j.gimo.2025.103474","relation":{},"ISSN":["2949-7744"],"issn-type":[{"value":"2949-7744","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell modeling and rescue of a novel noncoding genetic cause of glycogen storage disease IX","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gimo.2025.103474","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.","name":"copyright","label":"Copyright"}],"article-number":"103474"}}